[PHARMA] QoQ Cumulative Quarter Result on 30-Sep-2022 [#3]

Stock
[PHARMA] PHARMANIAGA BHD
Announcement Date
24-Nov-2022
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2022
Quarter
30-Sep-2022 [#3]
Profit Trend
QoQ- 30.28%
YoY- -57.23%
Quarter Report
Latest QR
Upcoming QR
PHARMA's Result
PHARMA's Financial Summary
View:
Show?
Cumulative Result
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
Revenue 1,729,188 880,454 3,510,677 2,647,957 1,723,276 962,174 4,815,015 -49.57%
PBT 15,535 9,193 -580,846 57,549 41,960 37,439 277,075 -85.42%
Tax -10,445 -6,427 -24,204 -18,402 -12,190 -8,583 -104,870 -78.60%
NP 5,090 2,766 -605,050 39,147 29,770 28,856 172,205 -90.50%
-
NP to SH 4,608 2,648 -607,317 37,073 28,456 27,734 172,150 -91.11%
-
Tax Rate 67.24% 69.91% - 31.98% 29.05% 22.93% 37.85% -
Total Cost 1,724,098 877,688 4,115,727 2,608,810 1,693,506 933,318 4,642,810 -48.42%
-
Net Worth -137,571 -142,812 -248,894 411,327 406,087 413,947 450,411 -
Dividend
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
Div - - 24,889 24,889 17,029 10,479 121,768 -
Div Payout % - - 0.00% 67.14% 59.84% 37.79% 70.73% -
Equity
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
Net Worth -137,571 -142,812 -248,894 411,327 406,087 413,947 450,411 -
NOSH 1,310,208 1,310,208 1,309,126 1,309,126 1,309,126 1,309,126 1,309,336 0.04%
Ratio Analysis
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
NP Margin 0.29% 0.31% -17.23% 1.48% 1.73% 3.00% 3.58% -
ROE 0.00% 0.00% 0.00% 9.01% 7.01% 6.70% 38.22% -
Per Share
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
RPS 131.98 67.20 268.00 202.14 131.55 73.45 367.74 -49.59%
EPS 0.35 0.20 -46.36 2.83 2.17 2.12 13.15 -91.14%
DPS 0.00 0.00 1.90 1.90 1.30 0.80 9.30 -
NAPS -0.105 -0.109 -0.19 0.314 0.31 0.316 0.344 -
Adjusted Per Share Value based on latest NOSH - 1,309,126
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
RPS 119.98 61.09 243.58 183.73 119.57 66.76 334.08 -49.56%
EPS 0.32 0.18 -42.14 2.57 1.97 1.92 11.94 -91.10%
DPS 0.00 0.00 1.73 1.73 1.18 0.73 8.45 -
NAPS -0.0955 -0.0991 -0.1727 0.2854 0.2818 0.2872 0.3125 -
Price Multiplier on Financial Quarter End Date
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
Date 30/06/23 31/03/23 30/12/22 30/09/22 30/06/22 31/03/22 31/12/21 -
Price 0.37 0.285 0.545 0.515 0.595 0.755 0.74 -
P/RPS 0.28 0.42 0.20 0.25 0.45 1.03 0.20 25.22%
P/EPS 105.20 141.02 -1.18 18.20 27.39 35.66 5.63 607.94%
EY 0.95 0.71 -85.07 5.50 3.65 2.80 17.77 -85.88%
DY 0.00 0.00 3.49 3.69 2.18 1.06 12.57 -
P/NAPS 0.00 0.00 0.00 1.64 1.92 2.39 2.15 -
Price Multiplier on Announcement Date
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
Date 11/08/23 18/05/23 27/02/23 24/11/22 19/08/22 20/05/22 17/02/22 -
Price 0.42 0.38 0.44 0.55 0.595 0.72 0.76 -
P/RPS 0.32 0.57 0.16 0.27 0.45 0.98 0.21 32.52%
P/EPS 119.42 188.02 -0.95 19.43 27.39 34.01 5.78 657.13%
EY 0.84 0.53 -105.37 5.15 3.65 2.94 17.30 -86.76%
DY 0.00 0.00 4.32 3.45 2.18 1.11 12.24 -
P/NAPS 0.00 0.00 0.00 1.75 1.92 2.28 2.21 -

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment